Log in with your email address username.


[Perspectives] Millions saved

“The problem with disease in Africa is that often, the tools are there, the knowledge is there, the people who can do it are there, and yet people keep on suffering from illness, and outbreaks and deaths.” This insightful commentary by Abraham Aseffa, Scientific Director at Ethiopia’s Armauer Hansen Research Institute, starts The Guardian Labs–Center for Global Development (CGD) video on the vaccine MenAfriVac, and the initiative to eliminate meningitis A across Africa’s meningitis belt. MenAfriVac, a meningococcal A conjugate vaccine, was administered to more than 217 million people in 2010–14, resulting in an estimated 142 000 lives saved and more than a million cases of meningitis prevented.